|Item#||Name||Size & Form||Brand||Price||Retail||Actions|
5 Billion viable cells per capsule when kept refrigerated and within Best Used Before Date.
GR-1 / RC-14 and Vaginal Flora (also called microbiota)
In one of the randomized clinical trials, 75% of women in the GR-1/RC-14 probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.
GR-1 / RC-14 â€“ 75%
Control Group â€“ 34%
**25+ Years of GR-1 / RC-14 Research/Clinical Studies
Fem-dophilus contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1 and Lactobacillus reuteri, RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.
*Statements on this site have not been evaluated by the Food and Drug Administration. Products on this site are not intended to diagnose, treat, cure, or prevent any disease.
Prices are subject to change at anytime and without notice. The majority of the product information has been reprinted from the manufacturer.